News from proteologics ltd

( RICS:PRTL)

Mar 18, 2013, 14:17 ET

Proteologics und GlaxoSmithKline (GSK) verlängern ihre Forschungskooperation um ein weiteres Jahr

Proteologics Ltd. (TASE: PRTL), ein führender Entwickler von auf dem Ubiquitin-System basierenden Medikamenten, gab heute bekannt, dass die...

Mar 18, 2013, 14:03 ET

Proteologics et GlaxoSmithKline (GSK) prolongent leur collaboration en matière de recherche d'une année supplémentaire

Proteologics Ltd. (TASE : PRTL), un laboratoire pharmaceutique de premier plan qui concentre ses recherches sur le système d'ubiquitination,...

Mar 18, 2013, 11:06 ET

Proteologics and GlaxoSmithKline (GSK) Extend Their Research Collaboration for an Additional Year

Proteologics Ltd. (TASE: PRTL), a leading drug developer based on the ubiquitin system, announced today that, under the terms of the 3- year...

Feb 21, 2013, 08:19 ET

Proteologics et Newcastle Innovation concluent un accord exclusif afin de développer et commercialiser des traitements pour l'asthme et d'autres maladies respiratoires

Le laboratoire pharmaceutique de premier plan Proteologics Ltd. (TASE : PRTL) et Newcastle Innovation Limited, société de...

Feb 20, 2013, 14:14 ET

Proteologics und Newcastle Innovation schließen Exklusivvertrag über Entwicklung und Vermarktung von Medikamenten gegen Asthma und andere Atemwegserkrankungen

Der marktführende Arzneimittelentwickler Proteologics Ltd. (TASE: PRTL) und Newcastle Innovation Limited, das Technologietransferunternehmen...

Feb 20, 2013, 07:55 ET

Proteologics and Newcastle Innovation Enter Exclusive Agreement to Develop and Commercialize Therapeutics for Asthma and Other Respiratory Diseases

Leading drug developer Proteologics Ltd. (TASE:PRTL) and Newcastle Innovation Limited, the technology transfer company of the University of...

Mar 05, 2001, 00:00 ET

Proteologics Announces Completion of $14 Million Financing Round

ORANGEBURG, New York, or REHOVOT, Israel, March 5 /PRNewswire/ -- Proteologics, Inc., a proteomics based drug discovery company, announced today...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer